Rocos Brett, Kato So, Lewis Stephen J, Shaffrey Christopher I, Lenke Lawrence G
Division of Spine Surgery, Department of Orthopaedic Surgery, Duke University, Durham, NC, USA.
AO Knowledge Forum Deformity, Davos, Switzerland.
Global Spine J. 2025 Mar;15(2):580-586. doi: 10.1177/21925682231201240. Epub 2023 Sep 8.
Cross-sectional international survey with literature review.
To evaluate the evidence for these strategies and to understand the current trends in prophylactic antibiotic use during ASD surgery through an international survey.
An online survey was conducted among international AO Spine members regarding the peri-operative management of patients with ASD. The details of perioperative systemic and topical antibiotic use were solicited. Descriptive data were summarized for the responding surgeons who perform at least 10 long-segment fusions of >5 levels extending to the pelvis annually.
The literature supports the use of prophylactic antibiotic effective against gram positive organisms. The use of topical vancomycin remains debated, and there is limited evidence for topical tobramycin use. A total of 116 responses were received. 74 (64%) surgeons use topical vancomycin, most usually deep to the fascia only 45 (61%). The most usual dose used is 1-2 g. 4 (3%) surgeons use topical tobramycin deep to fascia. Following surgery, 90 (78%) surgeons use prophylactic cephalosporin with 3 (3%) using cloxacillin, 5 (4%) using ciprofloxacin and 9 (8%) using vancomycin and 6 (5%) using clindamycin either in addition or alone.
The present survey identifies a trend towards systemic and topical antibiotic prophylaxis primarily targeted at gram positive pathogens. The use of topical tobramycin, proposedly effective against gram negative infections, remains uncommon. There is a lack of consensus in the selection of perioperative antibiotic prophylaxis, thus a prospective study of the rates of infection with each strategy would be useful to inform guidelines.
横断面国际调查并进行文献综述。
通过国际调查评估这些策略的证据,并了解成人脊柱畸形(ASD)手术期间预防性使用抗生素的当前趋势。
对国际AO脊柱学会成员进行了一项关于ASD患者围手术期管理的在线调查。询问了围手术期全身和局部使用抗生素的详细情况。对每年至少进行10例超过5个节段延伸至骨盆的长节段融合手术的受访外科医生的描述性数据进行了总结。
文献支持使用对革兰氏阳性菌有效的预防性抗生素。局部使用万古霉素仍存在争议,局部使用妥布霉素的证据有限。共收到116份回复。74名(64%)外科医生使用局部万古霉素,大多数仅在筋膜深层使用,共45名(61%)。最常用的剂量是1 - 2克。4名(3%)外科医生在筋膜深层使用局部妥布霉素。手术后,90名(78%)外科医生使用预防性头孢菌素,3名(3%)使用氯唑西林,5名(4%)使用环丙沙星,9名(8%)使用万古霉素,6名(5%)单独或额外使用克林霉素。
本次调查确定了主要针对革兰氏阳性病原体进行全身和局部抗生素预防的趋势。局部使用妥布霉素(据称对革兰氏阴性感染有效)的情况仍然不常见。围手术期抗生素预防的选择缺乏共识,因此对每种策略的感染率进行前瞻性研究将有助于制定指南。